179 related articles for article (PubMed ID: 20575035)
1. Normal ranges of angiogenesis regulatory proteins in human platelets.
Peterson JE; Zurakowski D; Italiano JE; Michel LV; Fox L; Klement GL; Folkman J
Am J Hematol; 2010 Jul; 85(7):487-93. PubMed ID: 20575035
[TBL] [Abstract][Full Text] [Related]
2. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients.
Peterson JE; Zurakowski D; Italiano JE; Michel LV; Connors S; Oenick M; D'Amato RJ; Klement GL; Folkman J
Angiogenesis; 2012 Jun; 15(2):265-73. PubMed ID: 22402885
[TBL] [Abstract][Full Text] [Related]
3. Expression of angiogenesis regulatory proteins and epithelial-mesenchymal transition factors in platelets of the breast cancer patients.
Han H; Cao FL; Wang BZ; Mu XR; Li GY; Wang XW
ScientificWorldJournal; 2014; 2014():878209. PubMed ID: 25379550
[TBL] [Abstract][Full Text] [Related]
4. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.
Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
Platelets; 2015; 26(6):577-82. PubMed ID: 25275728
[TBL] [Abstract][Full Text] [Related]
5. Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: relationship to platelet alpha-granule content and primary activation.
Gonzalez FJ; Rueda A; Sevilla I; Alonso L; Villarreal V; Torres E; Alba E
Int J Biol Markers; 2004; 19(3):221-8. PubMed ID: 15503824
[TBL] [Abstract][Full Text] [Related]
6. Platelet-Rich Plasma Powder: A New Preparation Method for the Standardization of Growth Factor Concentrations.
Kieb M; Sander F; Prinz C; Adam S; Mau-Möller A; Bader R; Peters K; Tischer T
Am J Sports Med; 2017 Mar; 45(4):954-960. PubMed ID: 27903591
[TBL] [Abstract][Full Text] [Related]
7. B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.
Kay NE; Bone ND; Tschumper RC; Howell KH; Geyer SM; Dewald GW; Hanson CA; Jelinek DF
Leukemia; 2002 May; 16(5):911-9. PubMed ID: 11986954
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates.
Kanter J; Khan SY; Kelher M; Gore L; Silliman CC
Clin Cancer Res; 2008 Jun; 14(12):3942-7. PubMed ID: 18559616
[TBL] [Abstract][Full Text] [Related]
9. Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts.
Starlinger P; Alidzanovic L; Schauer D; Brugger P; Sommerfeldt S; Kuehrer I; Schoppmann SF; Gnant M; Brostjan C
Dis Markers; 2011; 31(2):55-65. PubMed ID: 21896999
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
Etulain J; Mena HA; Negrotto S; Schattner M
Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
[TBL] [Abstract][Full Text] [Related]
11. Plasma platelet-derived growth factor-B chain is elevated in patients with extensively large brain tumour.
Kurimoto M; Nishijima M; Hirashima Y; Endo S; Takaku A
Acta Neurochir (Wien); 1995; 137(3-4):182-7. PubMed ID: 8789659
[TBL] [Abstract][Full Text] [Related]
12. Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma.
Yoon SS; Segal NH; Olshen AB; Brennan MF; Singer S
Ann Oncol; 2004 Aug; 15(8):1261-6. PubMed ID: 15277268
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of circulating angiogenic markers in prostate-specific antigen (PSA)-stable and PSA-progressive hormone-sensitive advanced prostate cancer.
Kohli M; Kaushal V; Spencer HJ; Mehta P
Urology; 2003 Apr; 61(4):765-9. PubMed ID: 12670562
[TBL] [Abstract][Full Text] [Related]
14. Platelets actively sequester angiogenesis regulators.
Klement GL; Yip TT; Cassiola F; Kikuchi L; Cervi D; Podust V; Italiano JE; Wheatley E; Abou-Slaybi A; Bender E; Almog N; Kieran MW; Folkman J
Blood; 2009 Mar; 113(12):2835-42. PubMed ID: 19036702
[TBL] [Abstract][Full Text] [Related]
15. Net platelet angiogenic activity (NPAA) correlates with progression and prognosis of non-small cell lung cancer.
Yao L; Dong H; Luo Y; Du J; Hu W
PLoS One; 2014; 9(4):e96206. PubMed ID: 24788022
[TBL] [Abstract][Full Text] [Related]
16. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Lupus; 2002; 11(6):348-55. PubMed ID: 12139372
[TBL] [Abstract][Full Text] [Related]
17. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
18. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.
Bambace NM; Levis JE; Holmes CE
Platelets; 2010; 21(2):85-93. PubMed ID: 20063989
[TBL] [Abstract][Full Text] [Related]
19. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets.
van Holten TC; Bleijerveld OB; Wijten P; de Groot PG; Heck AJ; Barendrecht AD; Merkx TH; Scholten A; Roest M
Cardiovasc Res; 2014 Jul; 103(1):140-6. PubMed ID: 24776597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
